3 completed, 1 terminated, 1 withdrawn. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Larynx Cancer: new trials by email Literature Review of Larynx Cancer trials Research Report on Larynx Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers Zimberelimab, Etrumadenant, Cisplatin - Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck | Phase 1 | Withdrawn | Jennifer Choe | 2023-12-31 | 2023-11-30 | |
| Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene A166 - HER2-positive Breast Cancer, HER2 Gene Mutation | Phase 1 / Phase 2 | Completed | Klus Pharma Inc. | 49 | 2018-07-16 | 2023-08-03 |
| WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer AZD1775, Cisplatin, Radiotherapy - Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma | Phase 1 | Completed | University of Birmingham | 9 | 2017-06-22 | 2024-09-19 |
| Pembrolizumab in Combination With CRT for LA-SCCHN pembrolizumab (MK-3475), Cisplatin, Radiation - Head and Neck Cancer, Squamous Cell Carcinoma | Phase 1 | Completed | Sanford Health | 59 | 2015-11-01 | 2025-10-07 |
| Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer Motexafin Gadolinium Injection - Head and Neck Cancer, Oropharynx Cancer | Phase 1 | Terminated | Pharmacyclics LLC. | 18 | 2007-05-08 |
Laryngeal Neoplasms (5) · Head and Neck Neoplasms (4) · Hypopharyngeal Neoplasms (3) · Mouth Neoplasms (3) · Oropharyngeal Neoplasms (3) · Squamous Cell Carcinoma of Head and Neck (2) · Tonsillar Neoplasms (2) · Bile Duct Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Mucoepidermoid (1) · Carcinoma, Renal Cell (1) · Carcinoma, Squamous Cell (1) · Cholangiocarcinoma (1) · Colonic Neoplasms (1) · Laryngeal Diseases (1)
Neoplasms (5) · Neoplasms by Site (5) · Otorhinolaryngologic Diseases (5) · Otorhinolaryngologic Neoplasms (5) · Respiratory Tract Diseases (5) · Respiratory Tract Neoplasms (5) · Carcinoma (4) · Laryngeal Diseases (4) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (4) · Pharyngeal Diseases (4) · Stomatognathic Diseases (4) · Mouth Diseases (3) · Pharyngeal Neoplasms (3) · Carcinoma, Squamous Cell (2)
Cisplatin (3) · Radiation (2) · Radiotherapy (1) · adavosertib (1) · motexafin gadolinium (1) · pembrolizumab (1) · zimberelimab (1)
Jennifer Choe (1) · Klus Pharma Inc. (1) · Pharmacyclics LLC. (1) · Sanford Health (1) · University of Birmingham (1)
United States (3) · United Kingdom (1)
Hisham Mehanna (1) · Jennifer Choe, MD, PhD (1) · Jordi Rodon Ahnert, MD, PhD (1) · Steven F Powell, MD (1)
2015 (1)